Diagnostic and prognostic biomarker discovery strategies for autoimmune disorders

Gibson, David S.; Banha, João; Penque, Deborah; Costa, Luciana; Conrads, Thomas P.; Cahill, Dolores J.; O'Brien, John K.; Rooney, Madeleine E.

http://hdl.handle.net/10400.18/156

Use this identifier to reference this record.

Name:	Description:	Size:	Format:
Diagnostic and prognostic biomarker discovery.pdf		571.76 KB	Adobe PDF	Download

Send Feedback

Authors

Abstract(s)

Current clinical, laboratory or radiological parameters cannot accurately diagnose or predict disease outcomes in a range of autoimmune disorders. Biomarkers which can diagnose at an earlier time point, predict outcome or help guide therapeutic strategies in autoimmune diseases could improve clinical management of this broad group of debilitating disorders. Additionally, there is a growing need for a deeper understanding of multi-factorial autoimmune disorders. Proteomic platforms offering a multiplex approach are more likely to reflect the complexity of autoimmune disease processes. Findings from proteomic based studies of three distinct autoimmune diseases are presented and strategies compared. It is the authors' view that such approaches are likely to be fruitful in the movement of autoimmune disease treatment away from reactive decisions and towards a preventative stand point.

Keywords

Proteomics Inflammation Autoimmune disease Behçets disease Juvenile idiopathic arthritis Dilated cardiomyopathy Genómica Funcional e Estrutural Determinantes Imunológicos em Doenças Crónicas